HB 326 – MontanaStatus: Inactive / Dead
Year Introduced: 2017
REQUIRING REPORTING OF PRICING FACTORS FOR CERTAIN PRESCRIPTION DRUGS: Each manufacturer that is responsible for the national drug code pricing of a prescription drug that is made available in Montana and whose wholesale acquisition cost increases by more than two times the increase in the consumer price index for medical care commodities in the previous year shall provide the following information: all factors that have contributed to the increased price of the drug; the percentage of the increased cost attributable to each factor; and an explanation of the role of each factor in contributing to the cost of the drug.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.